ASX:AC8 - Auscann Group Stock Price, News & Analysis

A$0.36
-0.02 (-5.26 %)
(As of 08/16/2019 04:00 PM ET)
Today's Range
A$0.36
Now: A$0.36
A$0.37
50-Day Range
A$0.34
MA: A$0.41
A$0.52
52-Week Range
A$0.30
Now: A$0.36
A$1.17
Volume1.02 million shs
Average VolumeN/A
Market Capitalization$111.31 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
AusCann Group Holdings Ltd researches, develops, cultivates, produces, and sells clinically validated cannabis medicines to patients in Australia. The company has a strategic partnership with Tasmanian Alkaloids. AusCann Group Holdings Ltd is headquartered in Joondalup, Australia.

Industry, Sector and Symbol

Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone61 0 9561 8834

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$53,814.00
Cash FlowA$0.12 per share
Book ValueA$0.14 per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$111.31 million
Next Earnings DateN/A
OptionableNot Optionable

Receive AC8 News and Ratings via Email

Sign-up to receive the latest news and ratings for AC8 and its competitors with MarketBeat's FREE daily newsletter.


Auscann Group (ASX:AC8) Frequently Asked Questions

What is Auscann Group's stock symbol?

Auscann Group trades on the ASX under the ticker symbol "AC8."

Has Auscann Group been receiving favorable news coverage?

Media stories about AC8 stock have been trending negative on Saturday, InfoTrie reports. InfoTrie identifies negative and positive press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Auscann Group earned a daily sentiment score of -2.3 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the immediate future. View News Stories for Auscann Group.

Who are some of Auscann Group's key competitors?

What other stocks do shareholders of Auscann Group own?

Who are Auscann Group's key executives?

Auscann Group's management team includes the folowing people:
  • Dr. Paul Donald Richard MacLeman MBA, BVSc, Grad Dip Tech, Grad Cert Eng, GAICD, MA, Interim CEO & Exec. Director (Age 53)
  • Mr. Quentin Heath Megson, Chief Operating & Financial Officer and Joint Company Sec. (Age 48)
  • Ms. Susan Patricia Hunter A.C.A., B.Com., BCom, F Fin, ACA, AGIA, FFin, GAIC, Company Sec. (Age 44)
  • Dr. Danial Schecter, Chief Medical Advisor (Age 45)

What is Auscann Group's stock price today?

One share of AC8 stock can currently be purchased for approximately A$0.36.

How big of a company is Auscann Group?

Auscann Group has a market capitalization of $111.31 million and generates $53,814.00 in revenue each year. View Additional Information About Auscann Group.

What is Auscann Group's official website?

The official website for Auscann Group is http://www.auscann.com.au/.

How can I contact Auscann Group?

The company can be reached via phone at 61 0 9561 8834.


MarketBeat Community Rating for Auscann Group (ASX AC8)

Community Ranking:  1.7 out of 5 (star)
Outperform Votes:  3 (Vote Outperform)
Underperform Votes:  6 (Vote Underperform)
Total Votes:  9
MarketBeat's community ratings are surveys of what our community members think about Auscann Group and other stocks. Vote "Outperform" if you believe AC8 will outperform the S&P 500 over the long term. Vote "Underperform" if you believe AC8 will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/17/2019 by MarketBeat.com Staff

Featured Article: What is a CD ladder?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel